Ursodeoxycholic acid is associated with a reduction in SARS‐CoV‐2 infection and reduced severity of COVID‐19 in patients with cirrhosis
John et al., Journal of Internal Medicine, doi:10.1111/joim.13630
https://c19early.org/john.html